Clinical trial
Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of…
NCT00356915 · Stiefel, a GSK Company, Industry · Completed
Key facts
| NCT number | NCT00356915 |
|---|---|
| Title | Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of the Toenail. |
| Official title | A Phase III Randomized, Evaluator-Blind, Parallel Group Study of the Safety and Efficacy of Itraconazole Tablets, Itraconazole Capsules and Placebo in the Treatment of Onychomycosis of the Toenail. |
| Lead sponsor | Stiefel, a GSK Company, Industry |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Onychomycosis |
| Intervention type | Drug |
| Interventions | Itraconazole 100mg capsules, Itraconazole 200mg tablets, Placebo tablets |
| Enrollment | 1,381 |
| Start date | Jul 1, 2006 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Jul 27, 2006 |
| Last update posted | Feb 9, 2017 |
| Countries | Canada, Dominican Republic, Ecuador, Honduras, Panama, South Africa, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: